White paper

Executive playbook: Optimizing the mature product portfolio

As the biopharmaceutical industry navigates global pricing and reimbursement constraints, competitive pressures, regulatory complexities, and policy reforms, it is also undergoing a reset regarding how it strategically manages mature product portfolios. Simply put, legacy maintenance and optimization models are not keeping pace with new market realities. 

Get strategic insights and best practices to help optimize your mature product portfolio, including:

  • Release: Options beyond divesting
  • Retain: Sustaining revenue streams
  • Reignite: Revitalizing mature products through market expansion 
  • Key strategic, operational, and structural considerations for outsourcing mature products 
  • An executive decision-making framework with critical questions to pose to your teams
MPO Playbook PDF Preview

Download the playbook to learn more

Connect with our team

Our team of leading value experts is dedicated to transforming evidence, policy insights, and market intelligence into effective global market access strategies. Let us help you navigate today’s complex healthcare landscape with confidence. Reach out to discover how we can support your goals.
blue abstract

Related resources

Article

CMC reality check: Late-stage risks that impact approval
A light-skinned person with long brown hair holding a tablet and stylus smiles at a colleague during a meeting in a conference room.

Factsheet

Cencora integrated submission readiness assessment

Article

Cell and gene therapies in the EU – Between scientific excellence and regulatory caution